Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV
- PMID: 12183239
- PMCID: PMC127449
- DOI: 10.1128/AAC.46.9.2865-2871.2002
Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV
Abstract
In a previous study, zidovudine (ZDV) was shown to cause a concentration-dependent inhibition of antigen-specific cytotoxic T-lymphocyte (CTL) clonal expansion (S. Francke, C. G. Orosz, K. A. Hayes, and L. E. Mathes, Antimicrob. Agents Chemother. 44:1900-1905, 2000). However, this suppressive effect was lost if exposure to ZDV was delayed for 24 to 48 h during the antigen sensitization period, suggesting that antigen-primed CTL may be less susceptible than naive T lymphocytes to the suppressive effects of ZDV. The present study was undertaken to determine if naive T lymphocytes were more sensitive to the suppressive effects of ZDV than T lymphocytes previously exposed to antigen. The 50% inhibitory concentration (IC(50)) values of ZDV were determined on naive and antigen-primed T-cell responses in an alloantigen system. Lymphocyte cultures with continuous antigen exposure (double prime) were more resistant to ZDV suppression (IC(50) = 316 micro M) than were naive lymphocytes (IC(50) = 87.5 micro M). Interestingly, lymphocytes that were antigen primed but deprived of antigen during the final 7 days of culture (prime/hold) were exquisitely sensitive to ZDV suppression (IC(50) = 29.3 micro M). The addition of 80 micro M ZDV during the initial priming of the single-prime (prime/hold) and double-prime cultures did not select for a more drug-resistant cell population. The differences in ZDV sensitivities are likely a reflection of the physiological properties of the lymphocytes related to their activation state.
Figures



Similar articles
-
Effect of zidovudine on the primary cytolytic T-lymphocyte response and T-cell effector function.Antimicrob Agents Chemother. 2000 Jul;44(7):1900-5. doi: 10.1128/AAC.44.7.1900-1905.2000. Antimicrob Agents Chemother. 2000. PMID: 10858351 Free PMC article.
-
Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.J Immunol. 1983 Jul;131(1):479-84. J Immunol. 1983. PMID: 6223080
-
Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.J Immunol. 1987 Aug 1;139(3):905-12. J Immunol. 1987. PMID: 2955052
-
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.Pediatr Infect Dis J. 2005 Jun;24(6):503-9. doi: 10.1097/01.inf.0000164787.63237.0b. Pediatr Infect Dis J. 2005. PMID: 15933559 Clinical Trial.
-
Revisiting the first long-term culture of antigen-specific cytotoxic T cells.Front Immunol. 2014 May 5;5:194. doi: 10.3389/fimmu.2014.00194. eCollection 2014. Front Immunol. 2014. PMID: 24829567 Free PMC article. Review. No abstract available.
Cited by
-
Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults.Int J Chronic Dis. 2018 Apr 18;2018:3702740. doi: 10.1155/2018/3702740. eCollection 2018. Int J Chronic Dis. 2018. PMID: 29850480 Free PMC article.
-
Anti-HIV Activity and Immunomodulatory Properties of Fractionated Crude Extracts of Alternaria alternata.Microorganisms. 2024 Jun 5;12(6):1150. doi: 10.3390/microorganisms12061150. Microorganisms. 2024. PMID: 38930532 Free PMC article.
References
-
- Andrew, M. E., V. L. Braciale, and T. J. Braciale. 1984. Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones. J. Immunol. 132:839-844. - PubMed
-
- Antonelli, G., O. Turriziani, M. Cianfriglia, E. Riva, G. Dong, A. Fattorossi, and F. Dianzani. 1992. Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein. AIDS Res. Hum. Retrovir. 8:1839-1844. - PubMed
-
- Antonelli, G., O. Turriziani, A. Verri, P. Narciso, F. Ferri, G. D'Offizi, and F. Dianzani. 1996. Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase. AIDS Res. Hum. Retrovir. 12:223-228. - PubMed
-
- Arts, E. J., and M. A. Wainberg. 1996. Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription. Adv. Virus Res. 46:97-163. - PubMed
-
- Avramis, V. I., R. Kwock, M. M. Solorzano, and E. Gomperts. 1993. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection. J. Acquir. Immune Defic. Syndr. 6:1287-1296. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical